Disclosure of speaker’s interests
No conflict of interest
Informal PrEP use among MSM
in Europe – first results from the
EU Flash PrEP survey
Kai J. Jonas
Maastricht University
Sascha Duken
University of Amsterdam
Richard Stranz, Adeline Bernier, Vincent Schlegel
AIDES, Paris, France
Informal PrEP use in Europe
• EU Flash PrEP Survey,
conducted Summer 2016
in 12 European countries
• N= 15.880
• N=312 informal PrEP users,
1.96% of total population
• Mean age 39, range 18-66
• Gender
• 303 male
• 5 transgender
• 4 female
–
–
–
–
–
–
–
–
–
–
–
–
–
Denmark 6
UK
65
France
19
Germany 149
Greece
4
Netherlands16
Italy
1
Portugal
3
Romania
0
Spain
6
Switzerland 9
Ireland
13
Other
21
Types of use:
Daily, intermittent and recreational
Duration
N (%)
Regimen
N (%)
I’m no longer
using it
116 (37.5)
Daily
155 (50.8)
129 (42.3)
Less than 3
months
65 (21)
Intermittent/ondemand
Other
21 (6.9)
3-6 months
59 (19.1)
7-12 months
40 (12.9)
More than a year
29 (9.4)
N
N (%)
(%)
Type of
medication
N (multiple
answers possible)
Intermittent
Intermittent
Regimen
regimen
Every
Severaltime
times you
a week
have sex
38
19 (26.8)
(13.3)
Truvada ®
192
Generic Truvada ®
113
Other
24
Once or twice a week
Just when you
Less than once a week
think it is risky
10 (7)
104 (73.2)
22 (15.4)
Once a month
21 (14.7)
Less than once a month
71 (49.7)
Adherence
More individuals on an
intermittent scheme of
PrEP use miss a dose
Missing a dose
Yes / No
Daily
59 / 96
Intermittent/ondemand
75 / 53
Other
9 / 10
Main reasons for missing a
dose were:
• Forgetting
• Running out of tablets
• No more sex
• Not being able to obtain
it anymore
Sourcing of PrEP
Main sources of PrEP were:
• Doctor‘s prescription (own payment)
• Via PEP
• Via HIV positive friends
• Online purchase
• Purchase generics in other countries
Costs of PrEP were:
• 0€ for 29.7% of the informal users
• Mean = 113€ (SD = 280, range 0.1 – 2000)
Medical Check-ups
Prior
(kidney/liver)
N (%)
During
use
overall
N (%)
Daily
N (%)
Interm.
N (%)
Yes
150 (48.1)
27 (18.2)
16 (16.2)
9 (25)
No
162 (51.9)
Once
before
start
Every three
months
96 (64.9)
71 (71.7) 16 (44.4)
Irregularly
25 (16.9)
12 (12.1)
Creatine use and informal
PrEP use: 17.7%
HIV testing
A lot lower
than before
Lower than
before
The same
N (%)
N (%)
N (%)
11 (30.6)
Higher than
before
A lot higher
than before
N (%)
N (%)
Daily
2 (1.3)
4 (2.6)
69 (45.4)
51 (33.6)
26 (17.1)
Intermittent
2 (1.4)
3 (2.1)
90 (63.4)
39 (27.5)
8 (5.6)
Medical Check-ups: HIV testing
Past HIV
testing
Past 12
months
Never
N
More
than a
year ago
N
Daily
148
7
0
Intermittent
141
6
3
N
HIV test
frequency/
12 month
1
2
3
4
5+
N
N
N
N
N
Daily
8
30
40
35
35
Intermittent
23
37
29
32
18
Condom use and HIV risk
assessment
Condom use
A lot lower
than before
Lower than
before
The same
N (%)
N (%)
N (%)
Daily
44 (28.9)
42 (27.6)
56 (36.8)
Intermittent
34 (23.8)
42 (29.4)
67 (46.9)
HIV risk
assessment
A lot lower
than before
Lower than
before
The same
N (%)
N (%)
N (%)
Higher than
before
A lot higher
than before
N (%)
N (%)
4 (2.6)
6 (3.9)
Higher than
before
A lot higher
than before
N (%)
N (%)
3 (2.0)
Daily
83 (55.7)
38 (25.5)
22 (14.8)
3 (2.0)
Intermittent
53 (36.8)
47 (32.6)
37 (25.7)
7 (4.9)
Informal use intention
Intention to
start PrEP use
(excl.
Romania)
No, definitely
not
No, probably
not
Maybe
Yes, probably
Yes, definitely
N (%)
N (%)
N (%)
N (%)
N (%)
When it becomes 1281 (9.0)
officially
available
2153 (15.2)
3712 (26.1)
3904 (27.5)
2885 (20.3)
Before it
becomes
officially
available
4345 (33.6)
2606 (18.9)
1136 (8.2)
550 (3.9)
4878 (34.3)
„Yes probably“ and „Yes definitely“ percentages do not differ by
country for informal use, but do differ for formal use intentions.
Thanks a lot!
Questions and feedback:
[email protected]